Cargando…

Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study

BACKGROUND: Rheumatoid arthritis (RA) is a long term condition that requires early treatment to control symptoms and improve long-term outcomes. Lack of response to RA treatments is not only a waste of healthcare resources, but also causes disability and distress to patients. Identifying biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Kanta, Peters, Sarah, Barton, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101686/
https://www.ncbi.nlm.nih.gov/pubmed/27825322
http://dx.doi.org/10.1186/s12891-016-1319-x
_version_ 1782466327463591936
author Kumar, Kanta
Peters, Sarah
Barton, Anne
author_facet Kumar, Kanta
Peters, Sarah
Barton, Anne
author_sort Kumar, Kanta
collection PubMed
description BACKGROUND: Rheumatoid arthritis (RA) is a long term condition that requires early treatment to control symptoms and improve long-term outcomes. Lack of response to RA treatments is not only a waste of healthcare resources, but also causes disability and distress to patients. Identifying biomarkers predictive of treatment response offers an opportunity to improve clinical decisions about which treatment to recommend in patients and could ultimately lead to better patient outcomes. The aim of this study was to explore the understanding of and factors affecting Rheumatoid Arthritis (RA) patients’ decisions around predictive treatment testing. METHODS: A qualitative study was conducted with a purposive sample of 16 patients with RA from three major UK cities. Four focus groups explored patient perceptions of the use of biomarker tests to predict response to treatments. Interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis by three researchers. RESULTS: Data were organised within three interlinking themes: [1] Perceptions of predictive tests and patient preference of tests; [2] Utility of the test to manage expectations; [3] The influence of the disease duration on take up of predictive testing. During consultations for predictive testing, patients felt they would need, first, careful explanations detailing the consequences of untreated RA and delayed treatment response and, second, support to balance the risks of tests, which might be invasive and/or only moderately accurate, with the potential benefits of better management of symptoms. CONCLUSIONS: This study provides important insights into predictive testing. Besides supporting clinical decision making, the development of predictive testing in RA is largely supported by patients. Developing strategies which communicate risk information about predictive testing effectively while reducing the psychological burden associated with this information will be essential to maximise uptake.
format Online
Article
Text
id pubmed-5101686
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51016862016-11-10 Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study Kumar, Kanta Peters, Sarah Barton, Anne BMC Musculoskelet Disord Research Article BACKGROUND: Rheumatoid arthritis (RA) is a long term condition that requires early treatment to control symptoms and improve long-term outcomes. Lack of response to RA treatments is not only a waste of healthcare resources, but also causes disability and distress to patients. Identifying biomarkers predictive of treatment response offers an opportunity to improve clinical decisions about which treatment to recommend in patients and could ultimately lead to better patient outcomes. The aim of this study was to explore the understanding of and factors affecting Rheumatoid Arthritis (RA) patients’ decisions around predictive treatment testing. METHODS: A qualitative study was conducted with a purposive sample of 16 patients with RA from three major UK cities. Four focus groups explored patient perceptions of the use of biomarker tests to predict response to treatments. Interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis by three researchers. RESULTS: Data were organised within three interlinking themes: [1] Perceptions of predictive tests and patient preference of tests; [2] Utility of the test to manage expectations; [3] The influence of the disease duration on take up of predictive testing. During consultations for predictive testing, patients felt they would need, first, careful explanations detailing the consequences of untreated RA and delayed treatment response and, second, support to balance the risks of tests, which might be invasive and/or only moderately accurate, with the potential benefits of better management of symptoms. CONCLUSIONS: This study provides important insights into predictive testing. Besides supporting clinical decision making, the development of predictive testing in RA is largely supported by patients. Developing strategies which communicate risk information about predictive testing effectively while reducing the psychological burden associated with this information will be essential to maximise uptake. BioMed Central 2016-11-08 /pmc/articles/PMC5101686/ /pubmed/27825322 http://dx.doi.org/10.1186/s12891-016-1319-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kumar, Kanta
Peters, Sarah
Barton, Anne
Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
title Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
title_full Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
title_fullStr Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
title_full_unstemmed Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
title_short Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
title_sort rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101686/
https://www.ncbi.nlm.nih.gov/pubmed/27825322
http://dx.doi.org/10.1186/s12891-016-1319-x
work_keys_str_mv AT kumarkanta rheumatoidarthritispatientperceptionsonthevalueofpredictivetestingfortreatmentsaqualitativestudy
AT peterssarah rheumatoidarthritispatientperceptionsonthevalueofpredictivetestingfortreatmentsaqualitativestudy
AT bartonanne rheumatoidarthritispatientperceptionsonthevalueofpredictivetestingfortreatmentsaqualitativestudy
AT rheumatoidarthritispatientperceptionsonthevalueofpredictivetestingfortreatmentsaqualitativestudy